Parliamentarians want a return to normal in Neuchâtel, thanks to the good vaccination rate –

The Swissmedic drug authority validated a booster of the Covid-19 vaccine on Tuesday for the most vulnerable people. They will be able to do this as early as six months after their second dose, starting next month. It is a dose of “memory” intended primarily to increase the individual resistance of the elderly. Because immunity decreases with age: this is called immunosenescence.

This therefore concerns all people over 65, with a stronger recommendation for those living in EMS or who have another disease.

“Antibody booster” with debated utility

As for the interest of an “antibody booster” for the whole population, its usefulness remains debated among scientists. Some countries have done so, Israel, for example, but in the current state of knowledge, vaccinated people remain well protected against severe forms of Covid-19.

But the priority for health authorities remains to convince people who have not yet been vaccinated of the value and harmlessness of vaccination.

>> Alexandra Richard’s details in Forum:

The third dose of Covid vaccine is now recommended from 65 years of age in Switzerland / Forum / 2 min. / yesterday at 6:00 p.m.

“It is quite logical to start with the most vulnerable people, but I think that by winter, we will open this third dose to the entire population,” said Jérôme Pugin, chief medical officer at the service. intensive care of the HUG, interviewed in the 7:30 p.m. of the RTS Tuesday.

This third dose will not be decisive for the control of the epidemic, but it will be “a plus”, he says.

Asked about the recent increase in cases of contamination despite vaccination, Jérôme Pugin does not give a direct explanation. “It is not entirely clear, we have not yet understood how we opened the tap and how it closed,” he admits. There may be a “holiday effect”, but no doubt that a new variant is also at work, says the specialist.

In this context, the new variant detected, a subgenus of the Delta variant called “Delta +”, could prove to be problematic. “It is difficult to make predictions (…), but it is clearly a variant which has a small advantage over the Delta variant in relation to its contagiousness”, he indicates.

>> The full interview with Jérôme Pugin in the 7:30 pm:

Jérôme Pugin, head doctor in intensive care at HUG: “By winter we will open the third dose to the entire population.” / 7:30 p.m. / 2 min. / yesterday at 7:30 p.m.
For Latest Updates Follow us on Google News

NEXT List Fritz also wants Covid bonus for mobile care